Is Vericel Corp Stock a Good Investment?

Vericel Corp Investment Advice

  VCEL
To provide specific investment advice or recommendations on Vericel Corp Ord stock, we recommend investors consider the following general factors when evaluating Vericel Corp Ord. This will help you to make an informed decision on whether to include Vericel Corp in one of your diversified portfolios:
  • Examine Vericel Corp's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Vericel Corp's leadership team and their track record. Good management can help Vericel Corp navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Biotechnology space and any emerging trends that could impact Vericel Corp's business and its evolving consumer preferences.
  • Compare Vericel Corp's performance and market position to its competitors. Analyze how Vericel Corp is positioned in terms of product offerings, innovation, and market share.
  • Check if Vericel Corp pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Vericel Corp's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Vericel Corp Ord stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Vericel Corp Ord is a good investment.
 
Sell
 
Buy
Cautious Hold
Our trade recommendation tool can be used to complement Vericel Corp Ord advice provided by experts. It analyzes the firm's potential to grow against your specific risk preferences and investment horizon. To make sure Vericel Corp Ord is not overpriced, please validate all Vericel Corp fundamentals, including its book value per share, total asset, and the relationship between the cash per share and target price . Given that Vericel Corp Ord has a number of shares shorted of 3.61 M, we advise you to double-check Vericel Corp Ord market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Very LowDetails

Economic Sensitivity

Almost mirrors the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Vericel Corp Stock

Researching Vericel Corp's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 357.33. Vericel Corp Ord had not issued any dividends in recent years. The entity had 1:20 split on the 16th of October 2013.
To determine if Vericel Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Vericel Corp's research are outlined below:
Vericel Corp Ord generated a negative expected return over the last 90 days
Over 99.0% of the company outstanding shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Colangelo Dominick of 26591 shares of Vericel Corp at 1.95 subject to Rule 16b-3
Vericel Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Vericel Corp Ord. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Vericel Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Vericel Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Vericel Corp's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-01
2024-06-30-0.08-0.1-0.0225 
2020-05-05
2020-03-31-0.08-0.1-0.0225 
2024-11-07
2024-09-30-0.05-0.020.0360 
2024-05-08
2024-03-31-0.11-0.080.0327 
2022-05-04
2022-03-31-0.12-0.15-0.0325 
2021-05-05
2021-03-31-0.04-0.07-0.0375 
2020-08-05
2020-06-30-0.21-0.180.0314 
2025-02-26
2024-12-310.340.380.0411 

Vericel Corp Target Price Consensus

Vericel target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Vericel Corp's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   8  Strong Buy
Most Vericel analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Vericel stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Vericel Corp Ord, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Vericel Corp Target Price Projection

Vericel Corp's current and average target prices are 46.26 and 64.25, respectively. The current price of Vericel Corp is the price at which Vericel Corp Ord is currently trading. On the other hand, Vericel Corp's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Vericel Corp Market Quote on 23rd of March 2025

Low Price45.13Odds
High Price47.44Odds

46.26

Target Price

Analyst Consensus On Vericel Corp Target Price

Low Estimate58.47Odds
High Estimate71.32Odds

64.25

Historical Lowest Forecast  58.47 Target Price  64.25 Highest Forecast  71.32
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Vericel Corp Ord and the information provided on this page.

Vericel Corp Analyst Ratings

Vericel Corp's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Vericel Corp stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Vericel Corp's financials, market performance, and future outlook by experienced professionals. Vericel Corp's historical ratings below, therefore, can serve as a valuable tool for investors.

Know Vericel Corp's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Vericel Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vericel Corp Ord backward and forwards among themselves. Vericel Corp's institutional investor refers to the entity that pools money to purchase Vericel Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-12-31
1.2 M
Federated Hermes Inc2024-12-31
1.1 M
Geneva Capital Management2024-12-31
1.1 M
Bnp Paribas Investment Partners Sa2024-12-31
1.1 M
Loomis, Sayles & Company Lp2024-12-31
M
Macquarie Group Ltd2024-12-31
923.2 K
Royal Bank Of Canada2024-12-31
895 K
New York State Common Retirement Fund2024-12-31
854.9 K
Dimensional Fund Advisors, Inc.2024-12-31
750.5 K
Blackrock Inc2024-12-31
8.2 M
Vanguard Group Inc2024-12-31
3.5 M
Note, although Vericel Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vericel Corp's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.32 B.

Market Cap

1.73 Billion

Vericel Corp's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets 0.02  0.03 
Return On Capital Employed 0.01  0.01 
Return On Assets 0.02  0.03 
Return On Equity 0.04  0.04 
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.
Determining Vericel Corp's profitability involves analyzing its financial statements and using various financial metrics to determine if Vericel Corp is a good buy. For example, gross profit margin measures Vericel Corp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Vericel Corp's profitability and make more informed investment decisions.

Evaluate Vericel Corp's management efficiency

Return On Tangible Assets is expected to rise to 0.03 this year. Return On Capital Employed is expected to rise to 0.01 this year. At this time, Vericel Corp's Intangible Assets are quite stable compared to the past year. Return On Tangible Assets is expected to rise to 0.03 this year, although the value of Non Currrent Assets Other will most likely fall to about 528.2 K. Vericel Corp's management efficiency ratios could be used to measure how well Vericel Corp manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 5.98  5.68 
Tangible Book Value Per Share 5.85  5.56 
Enterprise Value Over EBITDA 162.77  170.91 
Price Book Value Ratio 9.19  9.65 
Enterprise Value Multiple 162.77  170.91 
Price Fair Value 9.19  9.65 
Enterprise Value1.6 B1.7 B
Vericel Corp Ord benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Beta
1.792

Basic technical analysis of Vericel Stock

As of the 23rd of March, Vericel Corp has the Variance of 5.96, coefficient of variation of (817.36), and Risk Adjusted Performance of (0.10). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vericel Corp Ord, as well as the relationship between them. Please validate Vericel Corp Ord market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Vericel Corp is priced more or less accurately, providing market reflects its prevalent price of 46.26 per share. Given that Vericel Corp Ord has information ratio of (0.1), we advise you to double-check Vericel Corp Ord's current market performance to make sure the company can sustain itself at a future point.

Vericel Corp's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vericel Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vericel Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vericel Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Vericel Corp's Outstanding Corporate Bonds

Vericel Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vericel Corp Ord uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vericel bonds can be classified according to their maturity, which is the date when Vericel Corp Ord has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Vericel Corp's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Vericel Corp's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Vericel Corp's intraday indicators

Vericel Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Vericel Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Vericel Corp Corporate Filings

20th of March 2025
Other Reports
ViewVerify
F4
14th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
27th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F3
19th of February 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
Vericel Corp time-series forecasting models is one of many Vericel Corp's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vericel Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Vericel Stock media impact

Far too much social signal, news, headlines, and media speculation about Vericel Corp that are available to investors today. That information is available publicly through Vericel media outlets and privately through word of mouth or via Vericel internal channels. However, regardless of the origin, that massive amount of Vericel data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Vericel Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Vericel Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Vericel Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Vericel Corp alpha.

Vericel Corp Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Vericel Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Vericel Corp Ord Historical Investor Sentiment

Investor biases related to Vericel Corp's public news can be used to forecast risks associated with an investment in Vericel. The trend in average sentiment can be used to explain how an investor holding Vericel can time the market purely based on public headlines and social activities around Vericel Corp Ord. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Vericel Corp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vericel Corp and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Vericel Corp news discussions. The higher the estimate score, the more favorable the investor's outlook on Vericel Corp.

Vericel Corp Maximum Pain Price Across May 16th 2025 Option Contracts

Vericel Corp's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Vericel Corp close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Vericel Corp's options.

Vericel Corp Corporate Management

Mike GilliganSenior SalesProfile
Patrick FowlerSenior StrategyProfile
Sean FlynnChief OfficerProfile
MB FRCSEdChief OfficerProfile
Roland DeAngelisSenior OperationsProfile
Karen MahoneyChief OfficerProfile
Heidi HassenSenior ResourcesProfile
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.476
Earnings Share
0.2
Revenue Per Share
4.856
Quarterly Revenue Growth
0.16
Return On Assets
0.0072
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Vericel Corp's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.